The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is a five- year cooperative agreement funded by the United States Agency for International Development (USAID) and implemented by Management Sciences for Health (MSH). The goal of SIAPS is to improve the availability of quality pharmaceutical products and effective pharmaceutical services through strengthening pharmaceutical … Read more
The purpose of this standard operating procedure is to outline a step-by-step approach for undertaking active drug safety monitoring for the 9-month MDR-TB treatment regimen and other novel medications and regimens for TB and MDR-TB.
Management Sciences for Health (MSH) identified the Accreditation Council for Pharmacy Education (ACPE) as one of the partners in the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program proposal funded by the US Agency for International Development (USAID). ACPE is the national accreditation agency for quality assurance of pharmacy education in the United … Read more
In the Republic of Namibia, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program receives funding from the US Government to provide technical guidance for the development and implementation of innovative strategies and programs to strengthen pharmaceutical systems in support of the HIV/AIDS program. SIAPS is collaborating with USAID/Namibia to ensure the availability … Read more
The high burden of HIV and the rapid scale up of ARV treatment program in KwaZulu-Natal provided a unique opportunity to establish a cohort event monitoring system at selected sites within the province. The aim of the cohort event monitoring study was to implement and establish a system of active surveillance that would have resulted … Read more
The Ministry of Health (Ministério da Saúde; MINSA)’s National Directorate of Medicines and Equipment (Direccao Nacional de Medicamentos e Equipamentos; DNME) is responsible for regulating medicines and other pharmaceutical products in Angola in collaboration with the Inspectorate General of Health (Inspecção-Geral da Saúde; IGS). Preliminary reports indicated that the regulatory system was not fully functional … Read more
The world’s response to the AIDS pandemic of dramatically increased financial assistance to provide affordable medicines for HIV and AIDS did not automatically lead to access to antiretrovirals (ARVs). The effectiveness of these multimillion dollar initiatives was recognized to be limited by the capacity of the health care and pharmaceutical supply systems to deliver these … Read more
This manual is intended as to aid national tuberculosis program (NTP) managers, national pharmacovigilance center managers (NPV), tuberculosis (TB) service delivery providers, health care providers (physicians, pharmacists, nurses, public health officers and other health care professionals), academic institute staff, nongovernmental organizations, researchers, and any other staff working in organizations or individuals who are interested or … Read more
Inside this issue: Pre-service Pharmacy Training on Rational Medicine Use to Avert Antimicrobial Resistance in HIV, TB and other Public Health Diseases SCMS Supports the Ministry of Health and Social Services to Finalize and Award Tender Contracts for Anti-Retroviral Medicines Assuring Safety of Patients on ARV and Anti-TB Medicines through Enhanced Pharmacovigilance CAFO Fosters Community … Read more
The advent of highly active antiretroviral therapy (HAART) has led to significant reductions in morbidity and mortality; however, adverse effects are common, and may lead to discontinuation of therapy, dose interuption, and significant reductions in quality of life. Prompt identification and management of adverse effects are crucial to ensuring adherence to treatment and the success … Read more
